Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis

Area of Science:

• Nephrology
• Immunology
• Pathology

Background:

• Membranoproliferative glomerulonephritis (MPGN) is a progressive renal disease identified by specific histological features.
• Subtypes of MPGN are classified by glomerular deposit composition and location.
• MPGN II (dense deposit disease) is linked to alternative complement pathway dysregulation.

Purpose of the Study:

• To review current knowledge on MPGN pathogenesis.
• To introduce a novel classification system for MPGN based on pathogenesis.
• To highlight the importance of understanding MPGN pathogenesis for developing new treatments.

Main Methods:

• Review of existing literature on MPGN.
• Analysis of diagnostic criteria and classification systems.
• Discussion of complement pathway involvement and genetic factors.

Main Results:

• MPGN subtypes share common features but differ in deposit characteristics.
• Alternative complement pathway dysregulation is implicated in various MPGN subtypes.
• C3 Nephritic Factor (C3NeF) and AP regulatory protein mutations are found across MPGN types.

Conclusions:

• A pathogenesis-based classification of MPGN is proposed.
• Understanding MPGN mechanisms is key to developing targeted therapies.
• Further research into MPGN pathogenesis may improve patient outcomes and reduce disease recurrence.